首页 > 最新文献

Japanese Journal of Ophthalmology最新文献

英文 中文
Retinal vasculitis after intravitreal aflibercept 8 mg for neovascular age-related macular degeneration. 静脉注射阿弗利百普8毫克治疗新生血管性老年黄斑变性后出现视网膜血管炎。
IF 2.1 3区 医学 Q2 OPHTHALMOLOGY Pub Date : 2024-09-01 Epub Date: 2024-08-20 DOI: 10.1007/s10384-024-01107-w
Hidetaka Matsumoto, Junki Hoshino, Saki Numaga, Kaori Mimura, Yosuke Asatori, Hideo Akiyama

Purpose: To evaluate short-term outcomes of intravitreal injection of aflibercept 8 mg for neovascular age-related macular degeneration (nAMD).

Study design: Retrospective, interventional case series.

Methods: We retrospectively studied 35 eyes of 34 consecutive patients with nAMD, assessing best-corrected visual acuity (BCVA), foveal thickness (FT), and central choroidal thickness (CCT) before and 4 weeks after the initial intravitreal dose of aflibercept 8 mg. The rate of achieving a dry macula and the incidence of intraocular inflammation (IOI) at week 4 were also determined.

Results: BCVA showed significant improvement, with significant reductions in FT and CCT 4 weeks after the initial injection of aflibercept 8 mg (all P < 0.01), with a dry macula being achieved in 20 eyes (57.1%). However, 3 eyes (8.6%) developed non-infectious IOI associated with retinal vasculitis, an adverse event not reported previously. The IOI in these eyes was relatively mild and treated with a posterior subtenon injection of triamcinolone acetonide with or without betamethasone eye drops, resulting in amelioration of IOI without any visual loss.

Conclusions: Intravitreal aflibercept 8 mg appears to be effective for improving visual acuity and ameliorating exudative changes in eyes with nAMD. However, special attention should be given to the potential development of IOI associated with retinal vasculitis.

目的:评估玻璃体内注射阿弗利百普8毫克治疗新生血管性老年性黄斑变性(nAMD)的短期疗效:研究设计:回顾性、介入性病例系列:我们回顾性研究了连续34例nAMD患者的35只眼睛,在首次静脉注射阿弗利百普8毫克之前和之后4周评估了最佳矫正视力(BCVA)、眼窝厚度(FT)和脉络膜中央厚度(CCT)。此外,还测定了第4周黄斑干燥率和眼内炎症(IOI)发生率:结果:BCVA有明显改善,在首次注射阿弗利百普8毫克4周后,FT和CCT均有明显下降(均为P 结论:阿弗利百普8毫克玻璃体内注射剂可显著改善BCVA和CCT:静脉注射阿弗利百普8毫克似乎能有效改善nAMD患者的视力和渗出性改变。然而,应特别注意与视网膜血管炎相关的 IOI 的潜在发展。
{"title":"Retinal vasculitis after intravitreal aflibercept 8 mg for neovascular age-related macular degeneration.","authors":"Hidetaka Matsumoto, Junki Hoshino, Saki Numaga, Kaori Mimura, Yosuke Asatori, Hideo Akiyama","doi":"10.1007/s10384-024-01107-w","DOIUrl":"10.1007/s10384-024-01107-w","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate short-term outcomes of intravitreal injection of aflibercept 8 mg for neovascular age-related macular degeneration (nAMD).</p><p><strong>Study design: </strong>Retrospective, interventional case series.</p><p><strong>Methods: </strong>We retrospectively studied 35 eyes of 34 consecutive patients with nAMD, assessing best-corrected visual acuity (BCVA), foveal thickness (FT), and central choroidal thickness (CCT) before and 4 weeks after the initial intravitreal dose of aflibercept 8 mg. The rate of achieving a dry macula and the incidence of intraocular inflammation (IOI) at week 4 were also determined.</p><p><strong>Results: </strong>BCVA showed significant improvement, with significant reductions in FT and CCT 4 weeks after the initial injection of aflibercept 8 mg (all P < 0.01), with a dry macula being achieved in 20 eyes (57.1%). However, 3 eyes (8.6%) developed non-infectious IOI associated with retinal vasculitis, an adverse event not reported previously. The IOI in these eyes was relatively mild and treated with a posterior subtenon injection of triamcinolone acetonide with or without betamethasone eye drops, resulting in amelioration of IOI without any visual loss.</p><p><strong>Conclusions: </strong>Intravitreal aflibercept 8 mg appears to be effective for improving visual acuity and ameliorating exudative changes in eyes with nAMD. However, special attention should be given to the potential development of IOI associated with retinal vasculitis.</p>","PeriodicalId":14563,"journal":{"name":"Japanese Journal of Ophthalmology","volume":" ","pages":"531-537"},"PeriodicalIF":2.1,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11420316/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142004237","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Choroidal and retinal vascular changes in HLA-B27-associated anterior uveitis. HLA-B27相关前葡萄膜炎的脉络膜和视网膜血管变化。
IF 2.1 3区 医学 Q2 OPHTHALMOLOGY Pub Date : 2024-09-01 Epub Date: 2024-07-05 DOI: 10.1007/s10384-024-01080-4
Heejeong Chun, Joo Young Kim, Rae Young Kim, Mirinae Kim, Young-Gun Park, Young-Hoon Park

Purpose: To quantitatively analyze choroidal and retinal vascular changes in HLA-B27-associated anterior uveitis.

Study design: A retrospective study.

Methods: Medical records of 51 eyes with unilateral HLA-B27-associated anterior uveitis, their fellow eyes and 47 sex and age-matched healthy eyes were retrospectively reviewed. Their choroidal and retinal vasculature were analyzed using swept-source (SS) optical coherence tomography (OCT) and OCT angiography (OCTA) scans.

Results: Deep capillary plexus (DCP) vessel density (VD) (p < 0.001), choroidal vascularity index (CVI) (p = 0.012), and choriocapillary flow deficit (CCFD) (p < 0.001) of uveitic and fellow eye group were significantly higher than those of control group. On the contrary, superficial capillary plexus (SCP) VD (p < 0.001) of uveitic and fellow eye group were significantly lower than of control group. The vascular parameters of uveitis and fellow eye group showed no significant difference between uveitic and resolution period.

Conclusion: Certain choroidal and retinal vascular parameters were significantly changed in both HLA-B27-associated anterior uveitis without posterior segment involvement and the quiet fellow eyes, suggesting their possible effects as a systemic inflammatory disorder.

目的:定量分析HLA-B27相关前葡萄膜炎的脉络膜和视网膜血管变化:方法:回顾性研究:方法:回顾性研究51例单侧HLA-B27相关性前葡萄膜炎患者及其同侧眼和47例性别与年龄匹配的健康眼的病历。使用扫源(SS)光学相干断层扫描(OCT)和OCT血管造影(OCTA)扫描分析了他们的脉络膜和视网膜血管:结果:深毛细血管丛(DCP)血管密度(VD)(p 结论:某些脉络膜和视网膜血管密度较低:某些脉络膜和视网膜血管参数在无后节受累的HLA-B27相关性前葡萄膜炎和安静的同侧眼中都发生了显著变化,这表明它们可能是一种全身性炎症性疾病。
{"title":"Choroidal and retinal vascular changes in HLA-B27-associated anterior uveitis.","authors":"Heejeong Chun, Joo Young Kim, Rae Young Kim, Mirinae Kim, Young-Gun Park, Young-Hoon Park","doi":"10.1007/s10384-024-01080-4","DOIUrl":"10.1007/s10384-024-01080-4","url":null,"abstract":"<p><strong>Purpose: </strong>To quantitatively analyze choroidal and retinal vascular changes in HLA-B27-associated anterior uveitis.</p><p><strong>Study design: </strong>A retrospective study.</p><p><strong>Methods: </strong>Medical records of 51 eyes with unilateral HLA-B27-associated anterior uveitis, their fellow eyes and 47 sex and age-matched healthy eyes were retrospectively reviewed. Their choroidal and retinal vasculature were analyzed using swept-source (SS) optical coherence tomography (OCT) and OCT angiography (OCTA) scans.</p><p><strong>Results: </strong>Deep capillary plexus (DCP) vessel density (VD) (p < 0.001), choroidal vascularity index (CVI) (p = 0.012), and choriocapillary flow deficit (CCFD) (p < 0.001) of uveitic and fellow eye group were significantly higher than those of control group. On the contrary, superficial capillary plexus (SCP) VD (p < 0.001) of uveitic and fellow eye group were significantly lower than of control group. The vascular parameters of uveitis and fellow eye group showed no significant difference between uveitic and resolution period.</p><p><strong>Conclusion: </strong>Certain choroidal and retinal vascular parameters were significantly changed in both HLA-B27-associated anterior uveitis without posterior segment involvement and the quiet fellow eyes, suggesting their possible effects as a systemic inflammatory disorder.</p>","PeriodicalId":14563,"journal":{"name":"Japanese Journal of Ophthalmology","volume":" ","pages":"578-585"},"PeriodicalIF":2.1,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141534436","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The progress and future of corneal endothelial transplantation. 角膜内皮移植的进展与未来。
IF 2.1 3区 医学 Q2 OPHTHALMOLOGY Pub Date : 2024-09-01 Epub Date: 2024-07-31 DOI: 10.1007/s10384-024-01083-1
Toshiki Shimizu, Satoru Yamagami, Takahiko Hayashi

Endothelial transplantation has recently been accepted worldwide, in the long history of corneal transplantation. The introduction of endothelial keratoplasty (Descemet stripping automated endothelial keratoplasty and Descemet membrane endothelial keratoplasty) has enabled us to expand the surgical indications owing to the low incidence of rejection and quick recovery of visual function. New technologies have been developed to ensure stable postoperative outcomes with a shorter learning curve, such as transplantation using cultured human endothelial cells and induced pluripotent stem cells (iPS) or new devices such as artificial endothelium. This review discusses the history and characteristics of corneal transplantation alongside new treatment options that may offer hope for patients with endothelial disease in the future.

在角膜移植的悠久历史中,内皮移植近来已为全世界所接受。内皮角膜移植术(Descemet 剥离自动内皮角膜移植术和 Descemet 膜内皮角膜移植术)因其排斥反应发生率低、视功能恢复快而使我们得以扩大手术适应症。为了确保术后效果稳定,缩短学习曲线,我们开发了一些新技术,如使用培养的人类内皮细胞和诱导多能干细胞(iPS)进行移植,或使用人工内皮等新设备。本综述将讨论角膜移植的历史和特点,以及未来可能为内皮疾病患者带来希望的新治疗方案。
{"title":"The progress and future of corneal endothelial transplantation.","authors":"Toshiki Shimizu, Satoru Yamagami, Takahiko Hayashi","doi":"10.1007/s10384-024-01083-1","DOIUrl":"10.1007/s10384-024-01083-1","url":null,"abstract":"<p><p>Endothelial transplantation has recently been accepted worldwide, in the long history of corneal transplantation. The introduction of endothelial keratoplasty (Descemet stripping automated endothelial keratoplasty and Descemet membrane endothelial keratoplasty) has enabled us to expand the surgical indications owing to the low incidence of rejection and quick recovery of visual function. New technologies have been developed to ensure stable postoperative outcomes with a shorter learning curve, such as transplantation using cultured human endothelial cells and induced pluripotent stem cells (iPS) or new devices such as artificial endothelium. This review discusses the history and characteristics of corneal transplantation alongside new treatment options that may offer hope for patients with endothelial disease in the future.</p>","PeriodicalId":14563,"journal":{"name":"Japanese Journal of Ophthalmology","volume":" ","pages":"429-442"},"PeriodicalIF":2.1,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11420274/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141855469","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relationship between fundus sex index obtained using color fundus parameters and body height or axial length in the Kumejima population. 久米岛人群中使用彩色眼底参数获得的眼底性别指数与身高或轴长之间的关系。
IF 2.1 3区 医学 Q2 OPHTHALMOLOGY Pub Date : 2024-09-01 Epub Date: 2024-07-31 DOI: 10.1007/s10384-024-01082-2
Takehiro Yamashita, Ryo Asaoka, Aiko Iwase, Hiroshi Sakai, Hiroto Terasaki, Taiji Sakamoto, Makoto Araie

Purpose: To investigate the relationship between the fundus sex index obtained from fundus photographs and body height or axial length in the Kumejima population.

Study design: Prospective cross-sectional observational population study.

Methods: Using color fundus photographs obtained from the Kumejima population, 1,653 healthy right eyes with reliable fundus parameter measurements were included in this study. The tessellation fundus index was calculated as R/(R + G + B) using the mean value of the red-green-blue intensity in the eight locations around the optic disc and foveal region. The optic disc ovality ratio, papillomacular angle, and retinal vessel angle were quantified as previously described. The masculine or feminine fundus was quantified using machine learning (L2 regularized binominal logistic regression and leave one out cross validation), with the range of 0-1 as the predictive value, and defined as the fundus sex index. The relationship between the fundus sex index and body height or axial length was investigated using Spearman's correlation.

Results: The mean age of the 838 men and 815 women included in this study was 52.8 and 54.0 years, respectively. The correlation coefficient between fundus sex index and body height was - 0.40 (p < 0.001) in all, 0.01 (p = 0.89) in men, and - 0.04 (p = 0.30) in women, and that between fundus sex index and axial length was - 0.23 (p < 0.001) in all, - 0.12 (p < 0.001) in men, and - 0.13 (p < 0.001) in women.

Conclusion: This study shows that a larger number of masculine fundi tend to have longer axial lengths in each sex group. However, sex index was not significantly related with body height either in men or in women.

目的:在久米岛人群中调查通过眼底照片获得的眼底性别指数与身高或轴长之间的关系:研究设计:前瞻性横断面观察人群研究:使用从久米岛人群中获得的彩色眼底照片,将 1,653 只具有可靠眼底参数测量值的健康右眼纳入本研究。通过计算视盘和眼窝周围八个位置的红绿蓝强度平均值,以 R/(R + G + B) 表示魔方眼底指数。视盘椭圆率、视乳头角和视网膜血管角的量化方法如前所述。通过机器学习(L2 正则化二项式逻辑回归和留一交叉验证),以 0-1 为预测值范围,量化眼底的男性化或女性化,并将其定义为眼底性别指数。眼底性别指数与身高或轴长之间的关系采用斯皮尔曼相关性进行研究:838 名男性和 815 名女性的平均年龄分别为 52.8 岁和 54.0 岁。眼底性别指数与身高之间的相关系数为-0.40(p 结论:眼底性别指数与身高之间的相关系数为-0.40(p):本研究表明,在每个性别组中,男性眼底数量越多,轴向长度越长。然而,性别指数与男性或女性的身高均无明显关系。
{"title":"Relationship between fundus sex index obtained using color fundus parameters and body height or axial length in the Kumejima population.","authors":"Takehiro Yamashita, Ryo Asaoka, Aiko Iwase, Hiroshi Sakai, Hiroto Terasaki, Taiji Sakamoto, Makoto Araie","doi":"10.1007/s10384-024-01082-2","DOIUrl":"10.1007/s10384-024-01082-2","url":null,"abstract":"<p><strong>Purpose: </strong>To investigate the relationship between the fundus sex index obtained from fundus photographs and body height or axial length in the Kumejima population.</p><p><strong>Study design: </strong>Prospective cross-sectional observational population study.</p><p><strong>Methods: </strong>Using color fundus photographs obtained from the Kumejima population, 1,653 healthy right eyes with reliable fundus parameter measurements were included in this study. The tessellation fundus index was calculated as R/(R + G + B) using the mean value of the red-green-blue intensity in the eight locations around the optic disc and foveal region. The optic disc ovality ratio, papillomacular angle, and retinal vessel angle were quantified as previously described. The masculine or feminine fundus was quantified using machine learning (L2 regularized binominal logistic regression and leave one out cross validation), with the range of 0-1 as the predictive value, and defined as the fundus sex index. The relationship between the fundus sex index and body height or axial length was investigated using Spearman's correlation.</p><p><strong>Results: </strong>The mean age of the 838 men and 815 women included in this study was 52.8 and 54.0 years, respectively. The correlation coefficient between fundus sex index and body height was - 0.40 (p < 0.001) in all, 0.01 (p = 0.89) in men, and - 0.04 (p = 0.30) in women, and that between fundus sex index and axial length was - 0.23 (p < 0.001) in all, - 0.12 (p < 0.001) in men, and - 0.13 (p < 0.001) in women.</p><p><strong>Conclusion: </strong>This study shows that a larger number of masculine fundi tend to have longer axial lengths in each sex group. However, sex index was not significantly related with body height either in men or in women.</p>","PeriodicalId":14563,"journal":{"name":"Japanese Journal of Ophthalmology","volume":" ","pages":"586-593"},"PeriodicalIF":2.1,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11420305/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141855468","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and safety of the paul glaucoma implant in the treatment of refractory primary congenital glaucoma. 保罗青光眼植入体治疗难治性原发性先天性青光眼的有效性和安全性。
IF 2.1 3区 医学 Q2 OPHTHALMOLOGY Pub Date : 2024-09-01 Epub Date: 2024-06-27 DOI: 10.1007/s10384-024-01076-0
Murat Karapapak, Ali Olgun

Purpose: To evaluate the safety and efficacy of the PAUL Glaucoma Implant (PGI) for managing refractory primary congenital glaucoma (PCG) over a one-year period.

Study design: Retrospective.

Methods: A study was conducted using the medical records of thirty eyes of 17 patients who underwent PGI surgery for the treatment of refractory PCG. Primary outcome measures included failure criteria such as intraocular pressure (IOP) > 21 mm Hg, < 20% IOP reduction, necessity for further glaucoma intervention, implant removal, or loss of vision. Secondary outcomes focused on mean IOP, average number of glaucoma medications, best corrected visual acuity (logMAR), and incidence of complications.

Results: The mean preoperative IOP of 38.8 ± 9.2 mmHg significantly decreased to 16.1 ± 3.3 mmHg at 12 months postoperatively (p < 0.001). The average number of glaucoma medications reduced from 3.6 ± 0.5 preoperatively to 0.9 ± 1.2 at 12 months post-op. Visual acuity remained stable in 24 eyes, decreased in 4, and increased in 2. Early postoperative complications occurred in 13.3% of patients, but no late complications were reported. The cumulative success rate was 86.6%.

Conclusion: The PGI appears to be a safe and effective option for managing refractory primary congenital glaucoma, demonstrating significant IOP reduction and decreased dependence on glaucoma medications over a one-year period, with a high success rate and manageable complication profile.

目的:评估PAUL青光眼植入器(PGI)在一年内治疗难治性原发性先天性青光眼(PCG)的安全性和有效性:研究设计:回顾性:研究使用了接受 PGI 手术治疗难治性 PCG 的 17 名患者的 30 只眼睛的病历。主要结果指标包括眼压(IOP)> 21 mm Hg 等失败标准:结果:术前平均眼压(38.8 ± 9.2 mmHg)在术后 12 个月明显降低至(16.1 ± 3.3 mmHg)(p 结论:PGI 似乎是一种有效的治疗方法:PGI 似乎是治疗难治性原发性先天性青光眼的一种安全有效的方法,在一年的时间里,眼压明显降低,对青光眼药物的依赖性降低,成功率高,并发症也在可控范围内。
{"title":"Efficacy and safety of the paul glaucoma implant in the treatment of refractory primary congenital glaucoma.","authors":"Murat Karapapak, Ali Olgun","doi":"10.1007/s10384-024-01076-0","DOIUrl":"10.1007/s10384-024-01076-0","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the safety and efficacy of the PAUL Glaucoma Implant (PGI) for managing refractory primary congenital glaucoma (PCG) over a one-year period.</p><p><strong>Study design: </strong>Retrospective.</p><p><strong>Methods: </strong>A study was conducted using the medical records of thirty eyes of 17 patients who underwent PGI surgery for the treatment of refractory PCG. Primary outcome measures included failure criteria such as intraocular pressure (IOP) > 21 mm Hg, < 20% IOP reduction, necessity for further glaucoma intervention, implant removal, or loss of vision. Secondary outcomes focused on mean IOP, average number of glaucoma medications, best corrected visual acuity (logMAR), and incidence of complications.</p><p><strong>Results: </strong>The mean preoperative IOP of 38.8 ± 9.2 mmHg significantly decreased to 16.1 ± 3.3 mmHg at 12 months postoperatively (p < 0.001). The average number of glaucoma medications reduced from 3.6 ± 0.5 preoperatively to 0.9 ± 1.2 at 12 months post-op. Visual acuity remained stable in 24 eyes, decreased in 4, and increased in 2. Early postoperative complications occurred in 13.3% of patients, but no late complications were reported. The cumulative success rate was 86.6%.</p><p><strong>Conclusion: </strong>The PGI appears to be a safe and effective option for managing refractory primary congenital glaucoma, demonstrating significant IOP reduction and decreased dependence on glaucoma medications over a one-year period, with a high success rate and manageable complication profile.</p>","PeriodicalId":14563,"journal":{"name":"Japanese Journal of Ophthalmology","volume":" ","pages":"571-577"},"PeriodicalIF":2.1,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11420279/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141456914","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tear fluid cytokine analysis: a non-invasive approach for assessing retinopathy of prematurity severity. 泪液细胞因子分析:评估早产儿视网膜病变严重程度的无创方法。
IF 2.1 3区 医学 Q2 OPHTHALMOLOGY Pub Date : 2024-09-01 Epub Date: 2024-07-10 DOI: 10.1007/s10384-024-01084-0
Takashi Baba, Ryu Uotani, Kodai Inata, Shin-Ichi Sasaki, Yumiko Shimizu, Mazumi Miura, Yoshitsugu Inoue, Dai Miyazaki

Purpose: To determine whether there is a significant association between inflammatory cytokines in the tear fluid and the severity of Retinopathy of Prematurity (ROP).

Study design: Retrospective cohort study.

Methods: The cytokine levels in tear fluids were determined in 34 eyes with ROP and 18 eyes without ROP. There were 15 eyes with severe ROP requiring treatment and 19 eyes with mild ROP not requiring treatment. For severe ROP eyes, tear fluids were collected before treatment.

Results: Significantly higher levels of CCL2 and vascular endothelial growth factor (VEGF) were detected in eyes with severe ROP compared to eyes with mild ROP and no ROP. When assessed for cytokine levels that discriminate each disease group, CCL2 showed a significant odds ratio of 1.76 for severity change (/quintile, P = 0.032, after adjusting for birth weight). Correlation analysis showed that birth weight correlated with IL-1α levels, and decreased weight gain increased IFN-γ levels. We next determined tear fluid cytokines which discriminate severe ROP using receiver operating characteristics' analysis. We found that combination of higher CCL2 levels, higher VEGF levels, and lower IFN-γ levels in the tear fluid had a stronger predictive value for severe ROP (area under curve, 0.85).

Conclusion: The levels of CCL2, VEGF, and IFN-γ in tear fluid may serve as useful biomarkers for assessing the severity of ROP.

目的:确定泪液中的炎性细胞因子与早产儿视网膜病变(ROP)的严重程度是否存在显著关联:研究设计:回顾性队列研究:方法:对 34 只患有早产儿视网膜病变的眼睛和 18 只未患有早产儿视网膜病变的眼睛的泪液中的细胞因子水平进行测定。其中 15 只眼睛患有需要治疗的重度 ROP,19 只眼睛患有不需要治疗的轻度 ROP。重度 ROP 患者的泪液在治疗前采集:结果:与轻度 ROP 和未患 ROP 的眼睛相比,重度 ROP 眼睛的 CCL2 和血管内皮生长因子 (VEGF) 水平明显更高。在评估可区分各疾病组的细胞因子水平时,CCL2 与严重程度变化的几率比为 1.76(/五分位数,P = 0.032,调整出生体重后)。相关分析表明,出生体重与 IL-1α 水平相关,而体重增加会增加 IFN-γ 水平。接下来,我们利用接收器操作特征分析确定了可区分严重 ROP 的泪液细胞因子。我们发现,泪液中 CCL2 水平较高、VEGF 水平较高和 IFN-γ 水平较低的组合对重度 ROP 有更强的预测价值(曲线下面积为 0.85):结论:泪液中的 CCL2、血管内皮生长因子和 IFN-γ 水平可作为评估 ROP 严重程度的有用生物标志物。
{"title":"Tear fluid cytokine analysis: a non-invasive approach for assessing retinopathy of prematurity severity.","authors":"Takashi Baba, Ryu Uotani, Kodai Inata, Shin-Ichi Sasaki, Yumiko Shimizu, Mazumi Miura, Yoshitsugu Inoue, Dai Miyazaki","doi":"10.1007/s10384-024-01084-0","DOIUrl":"10.1007/s10384-024-01084-0","url":null,"abstract":"<p><strong>Purpose: </strong>To determine whether there is a significant association between inflammatory cytokines in the tear fluid and the severity of Retinopathy of Prematurity (ROP).</p><p><strong>Study design: </strong>Retrospective cohort study.</p><p><strong>Methods: </strong>The cytokine levels in tear fluids were determined in 34 eyes with ROP and 18 eyes without ROP. There were 15 eyes with severe ROP requiring treatment and 19 eyes with mild ROP not requiring treatment. For severe ROP eyes, tear fluids were collected before treatment.</p><p><strong>Results: </strong>Significantly higher levels of CCL2 and vascular endothelial growth factor (VEGF) were detected in eyes with severe ROP compared to eyes with mild ROP and no ROP. When assessed for cytokine levels that discriminate each disease group, CCL2 showed a significant odds ratio of 1.76 for severity change (/quintile, P = 0.032, after adjusting for birth weight). Correlation analysis showed that birth weight correlated with IL-1α levels, and decreased weight gain increased IFN-γ levels. We next determined tear fluid cytokines which discriminate severe ROP using receiver operating characteristics' analysis. We found that combination of higher CCL2 levels, higher VEGF levels, and lower IFN-γ levels in the tear fluid had a stronger predictive value for severe ROP (area under curve, 0.85).</p><p><strong>Conclusion: </strong>The levels of CCL2, VEGF, and IFN-γ in tear fluid may serve as useful biomarkers for assessing the severity of ROP.</p>","PeriodicalId":14563,"journal":{"name":"Japanese Journal of Ophthalmology","volume":" ","pages":"482-489"},"PeriodicalIF":2.1,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141563346","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intraocular kinetics of pathological ATP after photoreceptor damage in rhegmatogenous retinal detachment. 流变性视网膜脱离中感光器损伤后病理性 ATP 的眼内动力学。
IF 2.1 3区 医学 Q2 OPHTHALMOLOGY Pub Date : 2024-09-01 Epub Date: 2024-07-26 DOI: 10.1007/s10384-024-01087-x
Takashi Tachibana, Shoji Notomi, Jun Funatsu, Kohta Fujiwara, Shunji Nakatake, Yusuke Murakami, Shintaro Nakao, Takashi Kanamoto, Yasuhiro Ikeda, Tatsuro Ishibashi, Koh-Hei Sonoda, Toshio Hisatomi

Purpose: Extracellular Adenosine triphosphate (ATP) released by dying cells may cause a secondary cell death in neighboring cells in retinal degeneration. We investigated intraocular ATP kinetics to gain mechanical insights into the pathology in rhegmatogenous retinal detachment (RRD).

Study design: Retrospective clinical study.

Methods: Vitreous or subretinal fluids (SRF) were obtained from patients with RRD (n=75), macular hole (MH; n=20), and epiretinal membrane (ERM; n=35) during vitrectomy. ATP levels in those samples were measured by luciferase assay.

Results: Mean ATP levels in the vitreous from RRD patients were significantly higher compared to those from MH and ERM patients (2.3 and 0.3 nM, respectively. P<0.01). Mean ATP levels in the SRF from RRD (11.7 nM) were higher than those in the vitreous from RRD (P<0.01). Mean ATP levels in the vitreous with short durations (1-8 days) of RRD were higher compared to those with long durations (>8 days) (3.2 and 1.4 nM, respectively. P<0.05). Similarly, ATP in SRF with short durations were higher than those with long durations (23.8 and 3.6 nM, respectively. P<0.05). Furthermore, the concentrations of ectonucleoside triphosphate diphosphohydrolase-1 (ENTPD1), a major ATP degradative enzyme, in the vitreous from RRD were higher than those from MH/ERM (1.2 and 0.2 ng/ml, respectively. P<0.01). ENTPD1 expression was localized in the cytoplasm of CD11b-positive infiltrating cells in the vitreous and retinal cells.

Conclusion: ATP increased in the vitreous and SRF in RRD and decreased over time with an upregulation of ENTPD1. The kinetics indicate the pathological mechanism of the excessive extracellular ATP after RRD.

目的:在视网膜变性过程中,垂死细胞释放的细胞外三磷酸腺苷(ATP)可能会导致邻近细胞继发性死亡。我们研究了眼内 ATP 动力学,以便从力学角度了解流变性视网膜脱离(RRD)的病理:研究设计:回顾性临床研究:在玻璃体切除术中从RRD(75例)、黄斑孔(MH;20例)和视网膜外膜(ERM;35例)患者身上获取玻璃体或视网膜下液(SRF)。这些样本中的ATP水平通过荧光素酶检测法进行测量:结果:RRD 患者玻璃体内的平均 ATP 水平明显高于 MH 和 ERM 患者(分别为 2.3 和 0.3 nM)(P8 天)(分别为 3.2 和 1.4 nM)。结论RRD患者玻璃体和SRF中的ATP增加,并随着时间的推移随着ENTPD1的上调而减少。动力学表明了RRD后细胞外ATP过多的病理机制。
{"title":"Intraocular kinetics of pathological ATP after photoreceptor damage in rhegmatogenous retinal detachment.","authors":"Takashi Tachibana, Shoji Notomi, Jun Funatsu, Kohta Fujiwara, Shunji Nakatake, Yusuke Murakami, Shintaro Nakao, Takashi Kanamoto, Yasuhiro Ikeda, Tatsuro Ishibashi, Koh-Hei Sonoda, Toshio Hisatomi","doi":"10.1007/s10384-024-01087-x","DOIUrl":"10.1007/s10384-024-01087-x","url":null,"abstract":"<p><strong>Purpose: </strong>Extracellular Adenosine triphosphate (ATP) released by dying cells may cause a secondary cell death in neighboring cells in retinal degeneration. We investigated intraocular ATP kinetics to gain mechanical insights into the pathology in rhegmatogenous retinal detachment (RRD).</p><p><strong>Study design: </strong>Retrospective clinical study.</p><p><strong>Methods: </strong>Vitreous or subretinal fluids (SRF) were obtained from patients with RRD (n=75), macular hole (MH; n=20), and epiretinal membrane (ERM; n=35) during vitrectomy. ATP levels in those samples were measured by luciferase assay.</p><p><strong>Results: </strong>Mean ATP levels in the vitreous from RRD patients were significantly higher compared to those from MH and ERM patients (2.3 and 0.3 nM, respectively. P<0.01). Mean ATP levels in the SRF from RRD (11.7 nM) were higher than those in the vitreous from RRD (P<0.01). Mean ATP levels in the vitreous with short durations (1-8 days) of RRD were higher compared to those with long durations (>8 days) (3.2 and 1.4 nM, respectively. P<0.05). Similarly, ATP in SRF with short durations were higher than those with long durations (23.8 and 3.6 nM, respectively. P<0.05). Furthermore, the concentrations of ectonucleoside triphosphate diphosphohydrolase-1 (ENTPD1), a major ATP degradative enzyme, in the vitreous from RRD were higher than those from MH/ERM (1.2 and 0.2 ng/ml, respectively. P<0.01). ENTPD1 expression was localized in the cytoplasm of CD11b-positive infiltrating cells in the vitreous and retinal cells.</p><p><strong>Conclusion: </strong>ATP increased in the vitreous and SRF in RRD and decreased over time with an upregulation of ENTPD1. The kinetics indicate the pathological mechanism of the excessive extracellular ATP after RRD.</p>","PeriodicalId":14563,"journal":{"name":"Japanese Journal of Ophthalmology","volume":" ","pages":"500-510"},"PeriodicalIF":2.1,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141766111","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Changes in cataract and refractive surgery practice patterns among JSCRS members over the past 20 years. 过去 20 年中,JSCRS 会员的白内障和屈光手术实践模式的变化。
IF 2.1 3区 医学 Q2 OPHTHALMOLOGY Pub Date : 2024-09-01 Epub Date: 2024-07-13 DOI: 10.1007/s10384-024-01081-3
Masaki Sato, Kazutaka Kamiya, Ken Hayashi, Hitoshi Tabuchi, Takashi Kojima, Norihito Goto, Natsuko Hatsusaka, Hidemasa Torii, Mayumi Nagata, Kazunori Miyata

Purpose: To evaluate changes in cataract and refractive surgery practice patterns among members of the Japanese Society of Cataract and Refractive Surgery (JSCRS) over the past 20 years.

Study design: Questionnaire survey study.

Subjects and methods: Clinical surveys were conducted annually between February and April from 2004 to 2023. Survey questions covered various areas, including cataract surgical techniques, anesthesia, endophthalmitis prophylaxis, toric and presbyopia-correcting intraocular lenses (IOLs), complications, and refractive surgery.

Results: The highest (n=554 [36.8%]) and lowest (n=316 [19.1%]) numbers of responses were collected in 2012 and 2016, respectively. In perioperative management, the intraoperative use of polyvinyl alcohol-iodine solution and topical antibiotic prescription 3 days before surgery has increased. The use of intracameral injection at the end of surgery has also significantly increased, although it has not been established as common practice. In anesthesia, there is a clear polarization between the use of topical drops and tenon injection. The use of toric IOLs and presbyopia-correcting IOLs has significantly increased from 2010 to 2023. In the latter, the use of trifocal IOLs has particularly increased. Regarding IOL power calculations, the Barrett True K and the Barrett Universal II formulas are rapidly gaining popularity for application with and without post-laser vision correction, respectively. In refractive surgery, phakic IOLs and corneal refractive therapy have attracted considerable interest, followed by laser in situ keratomileusis.

Conclusions: Evaluation of annual clinical survey data over the past two decades provided valuable insights into the shifting practice patterns and clinical opinions among JSCRS members.

目的:评估日本白内障与屈光手术学会(JSCRS)会员在过去 20 年中白内障与屈光手术实践模式的变化:研究对象和方法:从 2004 年至 2023 年,每年 2 月至 4 月进行临床调查。调查问题涉及多个领域,包括白内障手术技术、麻醉、眼底病预防、散光和老花矫正人工晶体(IOL)、并发症和屈光手术:2012年和2016年收集到的回复数量分别最多(n=554 [36.8%])和最少(n=316 [19.1%])。在围手术期管理方面,术中使用聚乙烯醇-碘溶液和术前 3 天外用抗生素处方的情况有所增加。在手术结束时进行巩膜内注射的情况也显著增加,但尚未形成惯例。在麻醉方面,局部滴眼液和腱鞘注射的使用有明显的两极分化。从 2010 年到 2023 年,散光人工晶体和老花矫正人工晶体的使用显著增加。在后者中,三焦点人工晶体的使用尤其增多。在人工晶体功率计算方面,Barrett True K 和 Barrett Universal II 计算公式正在迅速普及,分别适用于激光后视力矫正和非激光后视力矫正。在屈光手术方面,相控人工晶体和角膜屈光治疗引起了广泛的关注,激光原位角膜磨镶术紧随其后:对过去二十年的年度临床调查数据进行评估,为了解 JSCRS 会员的临床实践模式和临床观点的变化提供了宝贵的信息。
{"title":"Changes in cataract and refractive surgery practice patterns among JSCRS members over the past 20 years.","authors":"Masaki Sato, Kazutaka Kamiya, Ken Hayashi, Hitoshi Tabuchi, Takashi Kojima, Norihito Goto, Natsuko Hatsusaka, Hidemasa Torii, Mayumi Nagata, Kazunori Miyata","doi":"10.1007/s10384-024-01081-3","DOIUrl":"10.1007/s10384-024-01081-3","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate changes in cataract and refractive surgery practice patterns among members of the Japanese Society of Cataract and Refractive Surgery (JSCRS) over the past 20 years.</p><p><strong>Study design: </strong>Questionnaire survey study.</p><p><strong>Subjects and methods: </strong>Clinical surveys were conducted annually between February and April from 2004 to 2023. Survey questions covered various areas, including cataract surgical techniques, anesthesia, endophthalmitis prophylaxis, toric and presbyopia-correcting intraocular lenses (IOLs), complications, and refractive surgery.</p><p><strong>Results: </strong>The highest (n=554 [36.8%]) and lowest (n=316 [19.1%]) numbers of responses were collected in 2012 and 2016, respectively. In perioperative management, the intraoperative use of polyvinyl alcohol-iodine solution and topical antibiotic prescription 3 days before surgery has increased. The use of intracameral injection at the end of surgery has also significantly increased, although it has not been established as common practice. In anesthesia, there is a clear polarization between the use of topical drops and tenon injection. The use of toric IOLs and presbyopia-correcting IOLs has significantly increased from 2010 to 2023. In the latter, the use of trifocal IOLs has particularly increased. Regarding IOL power calculations, the Barrett True K and the Barrett Universal II formulas are rapidly gaining popularity for application with and without post-laser vision correction, respectively. In refractive surgery, phakic IOLs and corneal refractive therapy have attracted considerable interest, followed by laser in situ keratomileusis.</p><p><strong>Conclusions: </strong>Evaluation of annual clinical survey data over the past two decades provided valuable insights into the shifting practice patterns and clinical opinions among JSCRS members.</p>","PeriodicalId":14563,"journal":{"name":"Japanese Journal of Ophthalmology","volume":" ","pages":"443-462"},"PeriodicalIF":2.1,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141603642","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of objective visual function following idebenone administration in patients with leber hereditary optic neuropathy. 评估勒伯遗传性视神经病变患者服用意地美酮后的客观视觉功能。
IF 2.1 3区 医学 Q2 OPHTHALMOLOGY Pub Date : 2024-09-01 Epub Date: 2024-07-05 DOI: 10.1007/s10384-024-01077-z
Yoichiro Masuda, Hiroto Ishikawa, Hitoshi Ishikawa, Takeshi Kezuka, Atsushi Miyazaki, Kenji Matsumoto, Fumi Gomi, Osamu Mimura, Keigo Shikishima, Tadashi Nakano, Masahiko Terao

Purpose: To objectively assess visual function in Leber's Hereditary Optic Neuropathy (LHON) patients; this study evaluated pre- and post-idebenone treatment changes in primary visual cortical (V1) responses using functional magnetic resonance imaging (fMRI), given the challenges in subjective testing due to central retinal ganglion cell damage.

Study design: A descriptive study involving four confirmed LHON patients.

Methods: Four patients received 900 mg/day of oral idebenone for 24 weeks. Baseline and post-treatment visual acuity, visual fields, and BOLD fMRI responses while passively viewed drifting contrast pattern visual stimuli were compared with self-reported symptoms.

Results: Post-idebenone, one patient showed positive trends across subjective tests, reported symptoms, and fMRI. Two patients had stable symptoms and fMRI responses; one improved on subjective tests, and another worsened slightly. Another patient improved in visual field tests despite worsening symptoms and fMRI trends.

Conclusion: fMRI may offer a valuable objective measure of visual functions in LHON and appears to be more relevant in assessing symptoms. Further research with more participants is needed to ascertain fMRI's role in developing objective visual assessments and treatment evaluation.

目的:为了客观评估勒伯遗传性视神经病变(LHON)患者的视觉功能,本研究使用功能磁共振成像(fMRI)评估了利眠宁治疗前后初级视觉皮层(V1)反应的变化,因为视网膜中央神经节细胞受损给主观测试带来了挑战:研究设计:一项涉及四名确诊 LHON 患者的描述性研究:四名患者连续 24 周每天口服 900 毫克的依地美酮。将基线和治疗后视力、视野以及被动观看漂移对比模式视觉刺激时的 BOLD fMRI 反应与自我报告的症状进行比较:结果:治疗后,一名患者在主观测试、报告症状和 fMRI 方面均表现出积极趋势。两名患者的症状和 fMRI 反应稳定;其中一名患者的主观测试有所改善,另一名患者则略有恶化。结论:fMRI 可为 LHON 患者的视觉功能提供一种有价值的客观测量方法,而且在评估症状方面似乎更具相关性。需要对更多参与者进行进一步研究,以确定 fMRI 在制定客观视觉评估和治疗评估中的作用。
{"title":"Assessment of objective visual function following idebenone administration in patients with leber hereditary optic neuropathy.","authors":"Yoichiro Masuda, Hiroto Ishikawa, Hitoshi Ishikawa, Takeshi Kezuka, Atsushi Miyazaki, Kenji Matsumoto, Fumi Gomi, Osamu Mimura, Keigo Shikishima, Tadashi Nakano, Masahiko Terao","doi":"10.1007/s10384-024-01077-z","DOIUrl":"10.1007/s10384-024-01077-z","url":null,"abstract":"<p><strong>Purpose: </strong>To objectively assess visual function in Leber's Hereditary Optic Neuropathy (LHON) patients; this study evaluated pre- and post-idebenone treatment changes in primary visual cortical (V1) responses using functional magnetic resonance imaging (fMRI), given the challenges in subjective testing due to central retinal ganglion cell damage.</p><p><strong>Study design: </strong>A descriptive study involving four confirmed LHON patients.</p><p><strong>Methods: </strong>Four patients received 900 mg/day of oral idebenone for 24 weeks. Baseline and post-treatment visual acuity, visual fields, and BOLD fMRI responses while passively viewed drifting contrast pattern visual stimuli were compared with self-reported symptoms.</p><p><strong>Results: </strong>Post-idebenone, one patient showed positive trends across subjective tests, reported symptoms, and fMRI. Two patients had stable symptoms and fMRI responses; one improved on subjective tests, and another worsened slightly. Another patient improved in visual field tests despite worsening symptoms and fMRI trends.</p><p><strong>Conclusion: </strong>fMRI may offer a valuable objective measure of visual functions in LHON and appears to be more relevant in assessing symptoms. Further research with more participants is needed to ascertain fMRI's role in developing objective visual assessments and treatment evaluation.</p>","PeriodicalId":14563,"journal":{"name":"Japanese Journal of Ophthalmology","volume":" ","pages":"548-555"},"PeriodicalIF":2.1,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141534435","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A short-term comparison of surgical results between an ab-externo microshunt and trabeculectomy with a main focus on postoperative corneal astigmatism. 腹腔外微分流术与小梁切除术手术效果的短期比较,主要关注术后角膜散光。
IF 2.1 3区 医学 Q2 OPHTHALMOLOGY Pub Date : 2024-09-01 Epub Date: 2024-08-29 DOI: 10.1007/s10384-024-01105-y
Hokuto Hamazaki, Ryoko Kaiya, Tadayoshi Kaiya, Shun Hasegawa, Tetsuya Yamamoto

Purpose: To compare surgical results between ab-externo microshunt surgery and trabeculectomy, focusing on postoperative corneal astigmatism.

Study design: Retrospective study.

Methods: Subjects were patients with glaucoma who underwent either standalone ab-externo microshunt surgery or trabeculectomy. Data on ophthalmic examinations obtained preoperatively and 1, 3, and 5 months postoperatively were analyzed. To assess corneal astigmatism, two separate data sets measured by anterior segment optical coherence tomography and autorefractometer were evaluated. Multivariate linear mixed model analyses were conducted to identify factors associated with the astigmatism changes.

Results: Sixty eyes were examined: 13 eyes underwent microshunt surgery, and 47 eyes underwent trabeculectomy. The total corneal astigmatism measurements by anterior segment optical coherence tomography (AS-OCT) were: - 1.15 ± 0.85 D and - 1.17 ± 0.81 D for the microshunt and trabeculectomy groups, respectively, preoperatively. At five months postoperatively they were - 0.92 ± 0.47 D and - 1.61 ± 0.83 D, respectively (P = 0.807 for the microshunt group and P = 0.005 for the trabeculectomy group: Wilcoxon signed-rank test). AS-OCT also indicated similar results for posterior corneal astigmatism. Autorefractometry also found the total corneal astigmatism was significantly changed only in the trabeculectomy group. The linear mixed model analysis revealed that trabeculectomy (P = 0.001), older age (P = 0.004), and longer postoperative period (P = 0.015) were correlated with greater astigmatism changes. The intraocular pressures significantly decreased following both surgical treatments.

Conclusions: Standalone ab-externo microshunt surgery has less effect on corneal astigmatism during a 5 month period than trabeculectomy. Both surgical procedures significantly reduced intraocular pressure.

目的:比较ab-externo微分流手术和小梁切除术的手术效果,重点关注术后角膜散光:研究设计:回顾性研究:研究对象:青光眼患者,接受独立的ab-externo微分流手术或小梁切除术。分析术前、术后 1、3 和 5 个月的眼科检查数据。为了评估角膜散光,对通过前段光学相干断层扫描和自动折射仪测量的两组独立数据进行了评估。进行了多变量线性混合模型分析,以确定与散光变化相关的因素:结果:共检查了 60 只眼睛:结果:60 只眼睛接受了检查:13 只眼睛接受了微分流手术,47 只眼睛接受了小梁切除术。前段光学相干断层扫描(AS-OCT)测得的总角膜散光度数为- 微分流手术组和小梁切除术组的术前总散光测量值分别为:1.15 ± 0.85 D 和 - 1.17 ± 0.81 D。术后五个月,这两组的视力分别为 - 0.92 ± 0.47 D 和 - 1.61 ± 0.83 D(微分流术组 P = 0.807,小梁切除术组 P = 0.005):Wilcoxon 符号秩检验)。AS-OCT 也显示了类似的角膜后散光结果。自动折射仪也发现,只有小梁切除术组的总角膜散光发生了显著变化。线性混合模型分析显示,小梁切除术(P = 0.001)、年龄较大(P = 0.004)和术后时间较长(P = 0.015)与散光变化较大有关。两种手术治疗后,眼压均明显下降:结论:与小梁切除术相比,单独的ab-externo微分流手术在5个月内对角膜散光的影响较小。两种手术方法都能明显降低眼压。
{"title":"A short-term comparison of surgical results between an ab-externo microshunt and trabeculectomy with a main focus on postoperative corneal astigmatism.","authors":"Hokuto Hamazaki, Ryoko Kaiya, Tadayoshi Kaiya, Shun Hasegawa, Tetsuya Yamamoto","doi":"10.1007/s10384-024-01105-y","DOIUrl":"10.1007/s10384-024-01105-y","url":null,"abstract":"<p><strong>Purpose: </strong>To compare surgical results between ab-externo microshunt surgery and trabeculectomy, focusing on postoperative corneal astigmatism.</p><p><strong>Study design: </strong>Retrospective study.</p><p><strong>Methods: </strong>Subjects were patients with glaucoma who underwent either standalone ab-externo microshunt surgery or trabeculectomy. Data on ophthalmic examinations obtained preoperatively and 1, 3, and 5 months postoperatively were analyzed. To assess corneal astigmatism, two separate data sets measured by anterior segment optical coherence tomography and autorefractometer were evaluated. Multivariate linear mixed model analyses were conducted to identify factors associated with the astigmatism changes.</p><p><strong>Results: </strong>Sixty eyes were examined: 13 eyes underwent microshunt surgery, and 47 eyes underwent trabeculectomy. The total corneal astigmatism measurements by anterior segment optical coherence tomography (AS-OCT) were: - 1.15 ± 0.85 D and - 1.17 ± 0.81 D for the microshunt and trabeculectomy groups, respectively, preoperatively. At five months postoperatively they were - 0.92 ± 0.47 D and - 1.61 ± 0.83 D, respectively (P = 0.807 for the microshunt group and P = 0.005 for the trabeculectomy group: Wilcoxon signed-rank test). AS-OCT also indicated similar results for posterior corneal astigmatism. Autorefractometry also found the total corneal astigmatism was significantly changed only in the trabeculectomy group. The linear mixed model analysis revealed that trabeculectomy (P = 0.001), older age (P = 0.004), and longer postoperative period (P = 0.015) were correlated with greater astigmatism changes. The intraocular pressures significantly decreased following both surgical treatments.</p><p><strong>Conclusions: </strong>Standalone ab-externo microshunt surgery has less effect on corneal astigmatism during a 5 month period than trabeculectomy. Both surgical procedures significantly reduced intraocular pressure.</p>","PeriodicalId":14563,"journal":{"name":"Japanese Journal of Ophthalmology","volume":" ","pages":"562-570"},"PeriodicalIF":2.1,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142107524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Japanese Journal of Ophthalmology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1